<SEC-DOCUMENT>0001185185-17-002344.txt : 20171113
<SEC-HEADER>0001185185-17-002344.hdr.sgml : 20171110
<ACCEPTANCE-DATETIME>20171113194224
ACCESSION NUMBER:		0001185185-17-002344
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20171108
FILED AS OF DATE:		20171113
DATE AS OF CHANGE:		20171113

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Mikolaitis Lora
		CENTRAL INDEX KEY:			0001647985

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-55473
		FILM NUMBER:		171197907

	MAIL ADDRESS:	
		STREET 1:		10161 PARK RUN DR.
		STREET 2:		SUITE 150
		CITY:			LAS VEGAS
		STATE:			NV
		ZIP:			89145

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BioSig Technologies, Inc.
		CENTRAL INDEX KEY:			0001530766
		STANDARD INDUSTRIAL CLASSIFICATION:	ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
		IRS NUMBER:				264333375
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		8441 WAYZATA BLVD
		STREET 2:		SUITE 240
		CITY:			MINNEAPOLIS
		STATE:			MN
		ZIP:			55426
		BUSINESS PHONE:		763-999-7330

	MAIL ADDRESS:	
		STREET 1:		8441 WAYZATA BLVD
		STREET 2:		SUITE 240
		CITY:			MINNEAPOLIS
		STATE:			MN
		ZIP:			55426
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>form4-mikolaitis111317.xml
<DESCRIPTION>OWNERSHIP DOCUMENT
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0306</schemaVersion>

    <documentType>4</documentType>

    <periodOfReport>2017-11-08</periodOfReport>

    <notSubjectToSection16>0</notSubjectToSection16>

    <issuer>
        <issuerCik>0001530766</issuerCik>
        <issuerName>BioSig Technologies, Inc.</issuerName>
        <issuerTradingSymbol>BSGM</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001647985</rptOwnerCik>
            <rptOwnerName>Mikolaitis Lora</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>C/O BIOSIG TECHNOLOGIES, INC.</rptOwnerStreet1>
            <rptOwnerStreet2>8441 WAYZATA BLVD., SUITE 240</rptOwnerStreet2>
            <rptOwnerCity>MINNEAPOLIS</rptOwnerCity>
            <rptOwnerState>MN</rptOwnerState>
            <rptOwnerZipCode>55426</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>1</isTenPercentOwner>
            <isOther>0</isOther>
            <officerTitle></officerTitle>
            <otherText></otherText>
        </reportingOwnerRelationship>
    </reportingOwner>

    <derivativeTable>
        <derivativeTransaction>
            <securityTitle>
                <value>Stock Option (Right to Buy)</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <value>1.57</value>
            </conversionOrExercisePrice>
            <transactionDate>
                <value>2017-11-08</value>
            </transactionDate>
            <deemedExecutionDate></deemedExecutionDate>
            <transactionCoding>
                <transactionFormType>4</transactionFormType>
                <transactionCode>A</transactionCode>
                <equitySwapInvolved>0</equitySwapInvolved>
            </transactionCoding>
            <transactionTimeliness></transactionTimeliness>
            <transactionAmounts>
                <transactionShares>
                    <value>75000</value>
                </transactionShares>
                <transactionPricePerShare>
                    <value>0</value>
                </transactionPricePerShare>
                <transactionAcquiredDisposedCode>
                    <value>A</value>
                </transactionAcquiredDisposedCode>
            </transactionAmounts>
            <exerciseDate>
                <footnoteId id="F1"/>
            </exerciseDate>
            <expirationDate>
                <value>2027-11-08</value>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common Stock</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>75000</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>325000</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </derivativeTransaction>
    </derivativeTable>

    <footnotes>
        <footnote id="F1">One-half of the option vested on the date of the grant and the remainder vests in its entirety on November 8, 2018, provided that the reporting person is providing services to the Issuer on the vesting date and subject to the terms and conditions of the BioSig Technologies, Inc. 2012 Equity Incentive Plan.</footnote>
    </footnotes>

    <ownerSignature>
        <signatureName>/s/ Kenneth L. Londoner, attorney-in-fact</signatureName>
        <signatureDate>2017-11-13</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
